Shopping Cart
- Remove All
- Your shopping cart is currently empty
ONO-8809 is a thromboxane A2 receptor antagonist. ONO-8809 inhibited the LTC4-induced airway hyperresponsiveness to histamine in a dose-dependent manner. Macrophage accumulation and matrix metalloproteinase-9 (MMP-9) activity in the stroke-negative area in the contralateral cerebral cortex to the stroke lesion of salt-loaded SHRSP and 8-iso-PGF2alpha-treated SHRSP were significantly reduced by ONO-8809 treatment.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | 2.869 € | 10-14 weeks | |
50 mg | 3.781 € | 10-14 weeks | |
100 mg | 5.225 € | 10-14 weeks |
Description | ONO-8809 is a thromboxane A2 receptor antagonist. ONO-8809 inhibited the LTC4-induced airway hyperresponsiveness to histamine in a dose-dependent manner. Macrophage accumulation and matrix metalloproteinase-9 (MMP-9) activity in the stroke-negative area i |
Alias | ONO8809 |
Molecular Weight | 596.66 |
Formula | C30H46BrNO4S |
Cas No. | 123288-47-1 |
Relative Density. | 1.214 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.